AU2002220736A1 - Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence - Google Patents

Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence

Info

Publication number
AU2002220736A1
AU2002220736A1 AU2002220736A AU2002220736A AU2002220736A1 AU 2002220736 A1 AU2002220736 A1 AU 2002220736A1 AU 2002220736 A AU2002220736 A AU 2002220736A AU 2002220736 A AU2002220736 A AU 2002220736A AU 2002220736 A1 AU2002220736 A1 AU 2002220736A1
Authority
AU
Australia
Prior art keywords
antagonists
urinary incontinence
opioid agonists
treating urinary
mixed opioid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU2002220736A
Other versions
AU2002220736B2 (en
Inventor
Thomas Christoph
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10059415A external-priority patent/DE10059415A1/en
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of AU2002220736A1 publication Critical patent/AU2002220736A1/en
Application granted granted Critical
Publication of AU2002220736B2 publication Critical patent/AU2002220736B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

AU2002220736A 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence Ceased AU2002220736B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10059415.8 2000-11-30
DE10059415A DE10059415A1 (en) 2000-11-30 2000-11-30 Use of weak opioids and mixed opioid agonists / antagonists for the treatment of urinary incontinence
PCT/EP2001/013911 WO2002043713A2 (en) 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence

Publications (2)

Publication Number Publication Date
AU2002220736A1 true AU2002220736A1 (en) 2002-08-15
AU2002220736B2 AU2002220736B2 (en) 2006-04-06

Family

ID=7665212

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2073602A Pending AU2073602A (en) 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
AU2002220736A Ceased AU2002220736B2 (en) 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU2073602A Pending AU2073602A (en) 2000-11-30 2001-11-28 Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence

Country Status (14)

Country Link
US (1) US7008939B2 (en)
EP (1) EP1337254B1 (en)
JP (1) JP2004527465A (en)
AT (1) ATE287265T1 (en)
AU (2) AU2073602A (en)
CA (1) CA2430281C (en)
DE (2) DE10059415A1 (en)
ES (1) ES2234933T3 (en)
HU (1) HUP0303285A3 (en)
MX (1) MXPA03004713A (en)
NZ (1) NZ526604A (en)
PL (1) PL204246B1 (en)
PT (1) PT1337254E (en)
WO (1) WO2002043713A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476280B2 (en) 2002-05-09 2013-07-02 Versi Group, Llc Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
US7964315B2 (en) * 2003-09-12 2011-06-21 Bdf Ip Holdings Ltd. Shutdown methods and designs for fuel cell stacks
EP1866995B1 (en) * 2005-03-11 2017-10-25 BDF IP Holdings Ltd. Shutdown methods and designs for fuel cell stacks
TW200800223A (en) * 2005-12-21 2008-01-01 Shire Pharmaceuticals Inc Transdermal delivery of meptazinol
US8883817B2 (en) * 2007-10-18 2014-11-11 Aiko Biotechnology Combination analgesic employing opioid and neutral antagonist
US8748448B2 (en) 2007-10-18 2014-06-10 Aiko Biotechnology Combination analgesic employing opioid agonist and neutral antagonist
CN102836122A (en) * 2011-06-24 2012-12-26 扬子江药业集团四川海蓉药业有限公司 Composition injection containing meptazinol hydrochloride, and preparation method thereof
CN105362213A (en) * 2015-02-13 2016-03-02 成都苑东药业有限公司 Meptazinol hydrochloride injection medicine composition and preparation method thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5354863A (en) * 1992-01-21 1994-10-11 G. D. Searle & Co. Opioid agonist compounds
GB9202238D0 (en) * 1992-02-03 1992-03-18 Wellcome Found Compounds
USRE36547E (en) * 1992-09-21 2000-02-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists
CN100475210C (en) * 1996-03-08 2009-04-08 尼科梅德丹麦有限公司 Modified release multiple-units dosage composition
US5859043A (en) * 1996-06-11 1999-01-12 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Method for maintaining kidney function during surgery or severe trauma under general anesthesia
AU6747698A (en) * 1997-04-11 1998-11-11 Nippon Shinyaku Co. Ltd. Remedies for frequent urination and urinary incontinence
US5840696A (en) * 1997-09-11 1998-11-24 Lippton; Howard Diuretic and antinatriuretic responses produced by the endogenous opioid-like peptide, nociceptin (orphanin FQ)
EP0913152B1 (en) * 1997-11-03 2001-12-19 Stada Arzneimittel Ag Stabilised combination of drugs comprising naloxone and an opioid analgesic
US6274591B1 (en) * 1997-11-03 2001-08-14 Joseph F. Foss Use of methylnaltrexone and related compounds
DE19947747A1 (en) * 1999-10-05 2001-04-12 Gruenenthal Gmbh Treatment of urinary incontinence using (+)-tramadol, O-demethyl-tramadol or O-demethyl-N-mono-desmethyl-tramadol, having strong effect on bladder function without side-effects or analgesic action
WO2003070175A2 (en) * 2002-02-15 2003-08-28 Howard Brooks-Korn Use of opioid compound to treat a neurologic or neurogenic disorder

Similar Documents

Publication Publication Date Title
GB2384437B (en) Urinary incontinence device and method of making same
HUP0401485A3 (en) Pharmaceutical composition containing combination of selected opioids with muscarine antagonists for treating urinary incontinence
AU2001275257A1 (en) Methods and devices for the treatment of urinary incontinence
HK1055078A1 (en) Method of treating pain using nalbuphine and opioid antagonists
AU2001286557A1 (en) Method of treating or preventing urinary incontinence using prostanoid ep1 receptor antagonists
IL166944A (en) Remedies or preventives for urinary frequency or urinary incontinence and morphinan derivatives having nitrogen-containing heterocyclic group
AU2001296397A1 (en) Apparatus and method for treating female urinary incontinence
AU2001297664A1 (en) Improved surgical instrument and method for treating female urinary incontinence
IL149600A0 (en) Novel methods and compositions involving opioids and antagonists thereof
EP1177787A3 (en) Use of an estrogen agonist/antagonist for treating cataracts
AU2001288825A1 (en) Bulking agent delivery method for treating incontinence
AU2002220736A1 (en) Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
AU2002255243A1 (en) Device for aiding urination and method of use thereof
HUP0303285A3 (en) Use of weak opioids and mixed opioid agonists/antagonists for preparing of pharmaceutical composition for treating urinary incontinence
AU2001243445A1 (en) Intra-urethral device for incontinence and method for making and using same
AU6482200A (en) Use of amh and/or amh agonists and/or amh antagonists for long-term control of female fertility
AU2002233210A1 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence
HUP0302430A3 (en) Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontience
SI1337254T1 (en) Use of weak opioids and mixed opioid agonists/antagonists for treating urinary incontinence
AU2962200A (en) Use of agonists or antagonists of mip-3a in therapy
HUP0303046A3 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence and pharmaceutical compositions containing them
AU2002233209A1 (en) Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU2002223688A1 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
HUP0303268A3 (en) Use of substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treating urinary incontinence
AU1196601A (en) Methods of diagnosing and treating urinary incontinence